TMO Quantitative Stock Analysis

Validea's guru fundamental report assigns Thermo Fisher Scientific (TMO), a large-cap medical equipment and supplies growth stock, a 77% rating using the Partha Mohanram P/B Growth Investor model. This academic-backed model, which seeks to identify low book-to-market stocks with sustained future growth, places TMO just below its 80% 'interest' threshold. While TMO passes most of the model's fundamental criteria, it notably fails on Advertising to Assets and Research and Development to Assets, providing specific areas for investor consideration.

Analysis

Thermo Fisher Scientific (TMO), a large-cap growth stock in the Medical Equipment & Supplies sector, scores a 77% based on Validea's P/B Growth Investor model, which operationalizes the academic research of Partha Mohanram. This score places TMO just below the 80% threshold that the model uses to indicate notable interest. The analysis reveals a company with strong underlying fundamentals in several key areas, successfully passing criteria for its book-to-market ratio, return on assets (ROA), cash flow from operations to assets, and stability in both ROA and sales variance. However, the model flagged two specific weaknesses: TMO failed the tests for Advertising to Assets and Research and Development to Assets. This indicates that while the company exhibits many characteristics of a durable growth investment, its spending on these two key growth drivers, relative to its asset base, does not meet the specific quantitative thresholds established by this particular academic strategy.

Key Decisions for Investors

• Investors should recognize TMO's solid fundamental profile, particularly in profitability and operational cash flow, as validated by the majority of the model's criteria.
• The failure to pass screens for Advertising to Assets and Research and Development to Assets warrants further due diligence to determine if these lower-than-expected ratios pose a risk to future growth or reflect a deliberate and efficient capital allocation strategy.
• Given the 77% score is just shy of the model's 'interest' threshold, TMO could be considered a watchlist candidate for growth-oriented portfolios, pending a deeper dive into the flagged R&D and advertising metrics.